Our study attempted to uncover the relationship between serum HO‐1 and long‐term outcomes after stroke, and we found that serum HO‐1 levels are inversely related to poor functional outcomes after 3 months, suggesting the possibility of HO‐1 acting as a neuroprotective target in stroke recovery. This evidence concerns the gene HMOX1 and stroke disorder.